Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772680 · ClinicalTrials.gov registry record · NA
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study
A NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01772680: Completed NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01772680 is a NA study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01772680, a NA study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary aim of this study is to measure zinc status and related proteins in patients with Thalassemia who have or do not have diabetes. The secondary aim will be to explore the effect of zinc supplementation on glucose metabolism in patients with thalassemia.
Interventions
- DIETARY_SUPPLEMENT Zinc Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01772680
The ClinicalTrials.gov registry entry for NCT01772680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc Supplementation is the first listed.
NCT01772680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01772680 about?
NCT01772680 is a clinical study titled "Zinc and Diabetes in Patients With Thalassemia: a Pilot Study". The primary aim of this study is to measure zinc status and related proteins in patients with Thalassemia who have or do not have diabetes. The secondary aim will be to explore the effect of zinc supplementation on glucose metabolism in patients with thalassemia.
What is the current status of trial NCT01772680?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-11. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01772680?
The interventions under investigation include: Zinc Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01772680?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.